OBI Pharma Inc (4174.TWO) Quote| Reuters.com
Edition:
United States

OBI Pharma Inc (4174.TWO)

4174.TWO on Gre Tai Securities Market of Chinese Taipei

510.00TWD
30 Jun 2016
Change (% chg)

-- (--)
Prev Close
NT$510.00
Open
NT$508.00
Day's High
NT$513.00
Day's Low
NT$505.00
Volume
657
Avg. Vol
1,410,637
52-wk High
NT$755.00
52-wk Low
NT$250.00

4174.TWO

Chart for 4174.TWO

About

OBI Pharma, Inc. is a Taiwan-based company principally engaged in the development new pharmaceuticals. The Company mainly operates its business through research and development of novel cancer and infectious disease therapies. It also develops next generation active immunotherapy for difficult to treat cancers, including lung,... (more)

Overall

Beta: 0.29
Market Cap(Mil.): NT$87,194.84
Shares Outstanding(Mil.): 170.97
Dividend: --
Yield (%): --

Financials

  4174.TWO Industry Sector
P/E (TTM): -- 41.10 35.71
EPS (TTM): -5.37 -- --
ROI: -13.01 -6.56 14.23
ROE: -13.01 -5.98 15.43

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : SinoPac Sec Inv Service
$23.00
Provider : MasterLink Securities Corporation
$81.00
Provider : MasterLink Securities Corporation
$58.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.